Pay in 4 interest-free payments of $35.00 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
negatively impact outcomes in the management of cancer patients
is a non-glycosylated heparin-binding growth factor that belongs to the FGF family
HIF1β/ARNT Polyclonal Antibody
Immunofluorescence analysis of C6 cells using eIF4A Rabbit pAb at dilution of 1:100
Alternative Name: JV18
RYR2 Polyclonal Antibody - E-AB-68253 Size:60μL negatively impact outcomes in theRYR2 Polyclonal Antibody Sizes: 60L, 120L, 200L Catalogue Numbers: E AB 68253 60, E AB 68253 120, E AB 68253 200 Citations, Manuals and MSDS Available upon request. Abbreviation: RYR2 Target Synonym: RYR2; ARVC2; ARVD2; RYR 2; RyR; VTSIP; RYR2 Research Areas: Cancer, Cardiovascular, Metabolism, Neuroscience, Signal Transduction Conjugation: Unconjugated Host: Rabbit Species Reactivity: Human, Mouse, Rat Application: WB, IF Isotype: IgG Clonality: